The data also showed that patients with lower level of TG2 expression detected in cancer tissues had longer disease free survival and overall survival as compared to the patients with higher TG2 expression, and TG2 expression level correlated to NSCLC recurrence. The gene discussed is TGM2; the disease is cancer.